Cargando…
肺癌靶向药物肝脏毒性作用研究进展
Targeted drugs aimed at driver gene, such as Geftinib, Erlotinib and Crizotinib, have an irreplaceable position in the therapy of advanced non-small cell lung cancer. Tese drugs bring beneft to patients, however, higher hepatotoxicity is also presented. Now, drug induced hepatotoxicity and its mecha...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000506/ https://www.ncbi.nlm.nih.gov/pubmed/25248711 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.09.08 |
Ejemplares similares
-
分子靶向药物应用于非小细胞肺癌维持治疗的研究进展
Publicado: (2010) -
非小细胞肺癌MET基因突变的机制及靶向药物研究进展
Publicado: (2020) -
自噬在EGFR-TKI类肿瘤靶向药物对肺癌的治疗和耐药中作用的研究进展
Publicado: (2016) -
非小细胞肺癌靶向治疗的靶点研究进展
Publicado: (2013) -
肺癌分子分型与靶向治疗研究进展
Publicado: (2012)